JP2017524743A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524743A5 JP2017524743A5 JP2017528767A JP2017528767A JP2017524743A5 JP 2017524743 A5 JP2017524743 A5 JP 2017524743A5 JP 2017528767 A JP2017528767 A JP 2017528767A JP 2017528767 A JP2017528767 A JP 2017528767A JP 2017524743 A5 JP2017524743 A5 JP 2017524743A5
- Authority
- JP
- Japan
- Prior art keywords
- bioactive agent
- composition
- matrix
- composition according
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462037492P | 2014-08-14 | 2014-08-14 | |
| US62/037,492 | 2014-08-14 | ||
| PCT/US2015/045402 WO2016025911A1 (en) | 2014-08-14 | 2015-08-14 | Compositions for stabilizing and delivering proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017524743A JP2017524743A (ja) | 2017-08-31 |
| JP2017524743A5 true JP2017524743A5 (cg-RX-API-DMAC7.html) | 2018-09-27 |
| JP6910949B2 JP6910949B2 (ja) | 2021-07-28 |
Family
ID=54011102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017528767A Active JP6910949B2 (ja) | 2014-08-14 | 2015-08-14 | タンパク質を安定化させ、送達するための組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10722468B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3179985A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6910949B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015301399B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2957966C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016025911A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102218427B1 (ko) | 2017-09-20 | 2021-02-22 | 차의과학대학교 산학협력단 | 단백질 약물을 포함하는 코아세르베이트 조성물 및 이를 포함하는 창상 치료제 |
| KR101883142B1 (ko) * | 2017-10-30 | 2018-07-30 | 아주대학교산학협력단 | Sdf1을 유효성분으로 포함하는 피부 색소 형성 조절용 조성물 또는 피부 미백용 조성물 |
| WO2019147824A1 (en) | 2018-01-26 | 2019-08-01 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor |
| EP3810085A1 (en) | 2018-06-20 | 2021-04-28 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| WO2019246271A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor |
| US20230041197A1 (en) | 2018-06-20 | 2023-02-09 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
| US20230312700A1 (en) | 2018-06-20 | 2023-10-05 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a tnf inhibitor |
| US12171764B2 (en) | 2018-06-20 | 2024-12-24 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor |
| US12227565B2 (en) | 2018-06-20 | 2025-02-18 | Biora Therapeutics, Inc. | Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine |
| WO2020028907A1 (en) | 2018-08-03 | 2020-02-06 | Brown University | Compositions and methods for improving the bioavailability of glp1 and analogues thereof |
| US12186590B2 (en) | 2018-10-19 | 2025-01-07 | University Of Rochester | Immune modulators in combination with radiation treatment for advanced pancreatic cancer |
| PE20212185A1 (es) | 2019-02-18 | 2021-11-11 | Lilly Co Eli | Formulacion de anticuerpos terapeuticos |
| MX2022001975A (es) | 2019-08-16 | 2022-03-11 | Applied Molecular Transport Inc | Composiciones, formulaciones y produccion y purificacion de interleucinas. |
| EP4464339A4 (en) * | 2022-01-13 | 2026-08-05 | Nat Cancer Ct | BIOCOMPATIBLE COMPOSITION FOR MARKING A TARGET LESION, AND ITS PREPARATION PROCESS |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB929406A (en) | 1958-12-22 | 1963-06-19 | Upjohn Co | A process for the production of encapsulated material |
| GB929401A (en) | 1958-12-22 | 1963-06-19 | Upjohn Co | Encapsulated emulsions and processes for their preparation |
| GB969808A (en) | 1962-06-08 | 1964-09-16 | Boots Pure Drug Co Ltd | Anthelmintic compositions and compounds |
| GB1413186A (en) | 1973-06-27 | 1975-11-12 | Toyo Jozo Kk | Process for encapsulation of medicaments |
| IT1148784B (it) | 1980-04-09 | 1986-12-03 | Eurand Spa | Procedimento per la preparazione di microcapsule in un veicolo liquido |
| US4794000A (en) | 1987-01-08 | 1988-12-27 | Synthetic Blood Corporation | Coacervate-based oral delivery system for medically useful compositions |
| US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
| US5330768A (en) * | 1991-07-05 | 1994-07-19 | Massachusetts Institute Of Technology | Controlled drug delivery using polymer/pluronic blends |
| US6235313B1 (en) | 1992-04-24 | 2001-05-22 | Brown University Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
| US6197346B1 (en) | 1992-04-24 | 2001-03-06 | Brown Universtiy Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
| EP0804249A2 (en) | 1994-03-15 | 1997-11-05 | Brown University Research Foundation | Polymeric gene delivery system |
| GB9506946D0 (en) * | 1995-04-04 | 1995-05-24 | Univ Strathclyde | Microgels |
| US6143211A (en) | 1995-07-21 | 2000-11-07 | Brown University Foundation | Process for preparing microparticles through phase inversion phenomena |
| US6025393A (en) * | 1995-09-25 | 2000-02-15 | Santen Pharmaceutical Co., Ltd. | Method for treatment of inflammatory intestinal diseases |
| US6423345B2 (en) * | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| DE69930753D1 (de) | 1998-09-01 | 2006-05-18 | Elan Corp Plc Dublin | Verfahren zur induktion der zellulären immunantwort und parenterale impfstoff-zusammensetzungen dazu |
| JP2003519651A (ja) * | 2000-01-14 | 2003-06-24 | ブラウン ユニバーシティ リサーチ ファウンデーション | 微紛化凍結乾燥粒子 |
| US6998137B2 (en) * | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| US20020106406A1 (en) * | 2000-12-08 | 2002-08-08 | Mchugh Anthony J. | Crystallizable/non-crystallizable polymer composites |
| JP2005500304A (ja) * | 2001-06-21 | 2005-01-06 | アルタス バイオロジックス インコーポレイテッド | 球状タンパク質粒子およびそれらの作製方法および使用方法 |
| CN1694689A (zh) * | 2002-09-30 | 2005-11-09 | 阿库斯菲尔公司 | 供吸入的缓释多孔微粒 |
| CA2522957C (en) * | 2003-04-23 | 2013-10-22 | Medarex, Inc. | Compositions and methods for the therapy of inflammatory bowel disease |
| US20080124400A1 (en) * | 2004-06-24 | 2008-05-29 | Angiotech International Ag | Microparticles With High Loadings Of A Bioactive Agent |
| US20060228352A1 (en) | 2005-02-24 | 2006-10-12 | Schoenberger Stephen P | TRAIL and methods of modulating T cell activity and adaptive immune responses using TRAIL |
| CA2639921C (en) | 2006-01-23 | 2014-01-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Microspheres comprising nanocapsules containing a lipophilic drug |
| US20100210792A1 (en) | 2006-12-05 | 2010-08-19 | David Taft | Drug delivery |
| JP4621218B2 (ja) | 2007-02-09 | 2011-01-26 | 有限会社バイオ研 | Th1誘導剤及びその製造方法 |
| US9814553B1 (en) * | 2007-10-10 | 2017-11-14 | Abbott Cardiovascular Systems Inc. | Bioabsorbable semi-crystalline polymer for controlling release of drug from a coating |
| US20090202642A1 (en) * | 2008-02-08 | 2009-08-13 | Xiao Huang | Drug Delivery System Comprising Microparticles and Gelation System |
| AU2009214307A1 (en) | 2008-02-13 | 2009-08-20 | Bayer Intellectual Property Gmbh | Drug delivery system with stabilising effect |
| US8673359B2 (en) | 2010-07-08 | 2014-03-18 | Brown University | Nanoparticle compositions and methods for improved oral delivery of active agents |
| WO2012018616A2 (en) | 2010-07-26 | 2012-02-09 | Anaphore, Inc. | Polypeptides that bind trail-r1 and trail-r2 |
| US20130101553A1 (en) | 2011-04-18 | 2013-04-25 | The Regents Of The University Of California | Inducing inactivation of fibrogenic myofibroblasts |
| CA2842514C (en) * | 2011-07-22 | 2018-12-18 | Innocore Technologies B.V. | Biodegradable, semi-crystalline, phase separated, thermoplastic multi-block copolymers for controlled release of biologically active compounds |
| US10765634B2 (en) | 2012-01-24 | 2020-09-08 | University of Pittsburgh—of the Commonwealth System of Higher Education | Controlled release formulations for the induction and proliferation of blood cells |
-
2015
- 2015-08-14 CA CA2957966A patent/CA2957966C/en active Active
- 2015-08-14 JP JP2017528767A patent/JP6910949B2/ja active Active
- 2015-08-14 US US15/503,891 patent/US10722468B2/en active Active
- 2015-08-14 AU AU2015301399A patent/AU2015301399B2/en active Active
- 2015-08-14 EP EP15756295.0A patent/EP3179985A1/en not_active Withdrawn
- 2015-08-14 WO PCT/US2015/045402 patent/WO2016025911A1/en not_active Ceased
-
2020
- 2020-06-23 US US16/909,493 patent/US11504329B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5649783B2 (ja) | Hcvプロドラッグ処方 | |
| JP5167345B2 (ja) | 薬剤を加速放出する腸溶コーティングを含む固体剤形 | |
| CN101321517B (zh) | 能够口服和活性成分快速释放的固体药物剂型 | |
| Tawfeek et al. | Colonic delivery of indometacin loaded PGA-co-PDL microparticles coated with Eudragit L100-55 from fast disintegrating tablets | |
| KR101799625B1 (ko) | 제약 또는 기능식품 투여 형태에 적합한 코팅 조성물 | |
| Marquette et al. | Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres | |
| JP6910949B2 (ja) | タンパク質を安定化させ、送達するための組成物 | |
| SI21394A2 (sl) | Farmacevtske pelete, ki vsebujejo tamsulozin | |
| EP3362052B1 (en) | Processes for preparing formulations for gastrointestinal-targeted therapies | |
| US20240408050A1 (en) | Dihydromyricetin spray-dried dispersion formulations and methods for forming them | |
| JP2006514698A (ja) | ナノ粒子生物活性物質 | |
| EP1729741A2 (en) | Polymeric drug delivery system for hydrophobic drugs | |
| EP4037659B1 (en) | Pharmaceutical composition comprising enzalutamide | |
| CN112972388A (zh) | 卡利拉嗪释放制剂 | |
| JP2023505714A (ja) | アルカリ剤及び腸溶性コーティング層を含む剤形 | |
| Kumar et al. | Solid dispersion-strategy to enhance solubility and dissolution of poorly water soluble drugs | |
| JP2016519133A (ja) | ポリマーフィルムコーティングされた医薬組成物の薬物放出プロフィールを安定化させるための方法 | |
| TW200829287A (en) | Short term slow release drug delivery system | |
| Yu et al. | Design of redispersible high-drug-load amorphous formulations: impact of ionic vs nonionic surfactants on processing and performance | |
| JP5841609B2 (ja) | Hcv感染症を処置するための医薬組成物 | |
| JP5758899B2 (ja) | 活性物質を含有するコーティングにより被覆されたペレット | |
| CN101668515A (zh) | 药物组合物和方法 | |
| WO2024120944A1 (en) | Delayed release composition with resistance against fed state gastric conditions | |
| CN103347931A (zh) | 制备用于药物剂型的稳定保护性衣层的粉末包衣剂 | |
| CN108113976B (zh) | Th-302制剂、制备方法及其用途 |